Phase 3 Expansion : Seven additional trials are underway to assess Retatrutides impact on obesity, Type 2 diabetes, and related metabolic conditions
Injection-site and systemic risks : Improper reconstitution or non-sterile technique can introduce bacteria or particulates into the solution, leading to localised infections, abscesses, or, in severe cases, systemic sepsis
GLP-1, or Glucagon-like peptide, is a hormone naturally secreted by the intestines
J Biol Chem 259(3):183441 Xie S, Zhang M, Shi W, Xing Y, Huang Y, Fang WX, Liu SQ, Chen MY, Zhang T, Chen S, Zeng X, Wang S, Deng W, Tang Q (2022) Long-term activation of glucagon-like peptide-1 receptor by dulaglutide prevents diabetic heart failure and metabolic remodeling in type 2 diabetes
Plant-based protein sources like tofu, tempeh, and hemp seeds activate the same GLP-1 pathways, making them equally effective for individuals following vegetarian or vegan dietary patterns
While most people tolerate them well, its helpful to know what side effects to expect, especially in the first few weeks of treatment: nausea vomiting diarrhea constipation headaches fatigue These symptoms are well-documented across clinical trials and often appear during the dose escalation phase
